Early prostate cancer--which treatment do men prefer and why? - Wikidata - wikimedia - TriplyDB

Early prostate cancer--which treatment do men prefer and why?

Early prostate cancer--which treatment do men prefer and why?

http://www.wikidata.org/entity/Q43916829

about

Active surveillance as a practical strategy to differentiate lethal and non-lethal prostate cancer subtypes Factors that influence patient preferences for prostate cancer management options: A systematic review.Development and preliminary testing of PROGRESS: a Web-based education program for prostate cancer survivors transitioning from active treatment.Treatment decisions for localized prostate cancer: a concept mapping approach Early experience in MRI-guided therapies of prostate cancer: HIFU, laser and photodynamic treatment.RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitization.Reduced radiation tolerance of penile structures associated with dose-escalated hypofractionated prostate radiotherapy Our results of active surveillance for localized prostate cancer patients.Role of active surveillance in the management of localized prostate cancer.Factors influencing patients' acceptance and adherence to active surveillance Prostate brachytherapy in Ghana: our initial experience.'The thing is not knowing': patients' perspectives on surveillance of an indeterminate pulmonary nodule.Choice between prostatectomy and radiotherapy when men are eligible for both: a randomized controlled trial of usual care vs decision aid.A systematic review of patient preference elicitation methods in the treatment of colorectal cancer.Expectant management for men with early stage prostate cancer.Acknowledging unreported problems with active surveillance for prostate cancer: a prospective single-centre observational study.Does Travel Time to a Radiation Facility Impact Patient Decision-Making Regarding Treatment for Prostate Cancer? A Study of the New Hampshire State Cancer Registry.Erectile function following brachytherapy, external beam radiotherapy, or radical prostatectomy in prostate cancer patients.How Men with Prostate Cancer Choose Specialists: A Qualitative Study.A single institution study on patient's self-reporting appraisal and functional outcomes of the first set of men following radical perineal prostatectomy.Oncologic outcomes following radical prostatectomy in the active surveillance era.Canadian Men's perspectives about active surveillance in prostate cancer: need for guidance and resources.Predicting prostate cancer treatment choices: The role of numeracy, time discounting, and risk attitudes.Segmental dosimetry, toxicity and long-term outcome in patients with prostate cancer treated with permanent seed implants.Factors Associated with Men's Assessment of Prostate Cancer Treatment Choice.Treatment decision making in early-stage papillary thyroid cancer.Optimizing active surveillance strategies to balance the competing goals of early detection of grade progression and minimizing harm from biopsies.Cognitive factors influencing treatment decision-making in patients with localised prostate cancer: development of a standardised questionnaire.Patient and provider experiences with active surveillance: A scoping review.Prostate Cancer Patient Characteristics Associated With a Strong Preference to Preserve Sexual Function and Receipt of Active Surveillance.Emotional Distress Increases the Likelihood of Undergoing Surgery among Men with Localized Prostate Cancer.Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study.Active surveillance for prostate cancer: a systematic review of contemporary worldwide practices.Observations and outcomes of urethroplasty for bulbomembranous stenosis after radiation therapy for prostate cancer.EVOLUTION IN MANAGEMENT OF STAGE I SEMINOMA: THE CASE FOR PATIENT PREFERENCE AND PATIENT/CLINICIAN JOINT INTERNET REGISTRATION AND FOLLOW-UP STUDY TO QUANTIFY LATE EVENTS

P2860

Q27010695-233217CB-B6BC-44D6-8186-9A1D7BE1A655 Q28082911-DBD50A04-9216-40FC-A42B-BFF9F7B9DCF1 Q30661385-8B9AF8AB-E11B-476E-B53C-1B97C90999FD Q34028603-27F597A5-CBA9-4BF4-93C6-D818C7746AE9 Q34107347-6C0CE57E-DA85-486A-A64C-3A8F280D7019 Q34517369-AF17C608-FA8E-4566-880F-F61EC208A570 Q35892380-070D0057-66BB-4939-87C9-24701988FBC7 Q35993855-BB9A77FB-043B-46DE-8761-7239F51ED99F Q36520452-5F443563-6A94-4AC6-901A-D6F643AF1DB1 Q36520463-A7E2D1EF-6C50-4B5C-82A3-467F40899A31 Q37424403-4017ECE0-79AA-4500-A3F5-453EF582B796 Q37431814-C7A9B8A8-E6CB-4DB9-887D-85A7C6613E2D Q38033742-67EFDE73-B4B9-4025-9F23-AE398D161B7C Q38243162-6E9A4AFA-797E-445A-8F5A-9BB8C5899B63 Q38469754-B01CE9BE-BC64-4541-AB24-0FE4D03809DC Q38583764-B24E0EE3-B368-40A6-9C3E-FFB7ABE618FB Q39175142-A8A73BF0-A64C-4055-BEB2-AF9165C3C6D2 Q40162552-58729F87-7858-4928-BB9B-458065FB7160 Q40256827-F406F1BF-F691-42BA-8F59-C4A6A2F05D8D Q41948868-A6361A88-303D-446F-9BA1-51DDF372E066 Q43089360-A005A27C-EF27-4E75-86B5-2905697DF839 Q43248234-6E4C68BA-70C4-4D14-871D-0FDA4DDF2E97 Q45022828-647FC87F-68E7-483D-8E48-009EA38B07E2 Q45201919-629C0910-69D9-4D47-9EBE-1E690D6F254D Q46224066-6F5DCD79-A729-4698-B8C8-CA0AC63C6946 Q47369248-1685ECC0-9F34-4643-95A1-891DA034E016 Q47608517-572C3023-CDD8-4741-9BC2-705F4CBC9338 Q47665244-C3663B1D-9A44-4712-80FA-BE7E69BB308C Q48105242-8D899582-4169-434A-A674-CB6DAE1D0417 Q50089850-A13E0CF4-6BD2-4E65-833F-6AEA95AC145E Q50257610-6C5EF9FD-8A56-41EB-A6D6-2D0418BCF2F2 Q51248430-4B9AC68C-B004-4EEC-A2FB-474CB3C0E92A Q52624216-9C83B747-732D-439D-93CC-C4FFBC84CF17 Q53215676-016186C8-4F99-46D9-A6BA-958DA5A9E5D9 Q58234322-A33D5E8F-5F90-4687-8E6C-0B6876C5F142

P2860

Early prostate cancer--which treatment do men prefer and why?

http://www.wikidata.org/entity/Q43916829

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Early prostate cancer--which treatment do men prefer and why?

@en

Early prostate cancer--which treatment do men prefer and why?

@nl

type

label

Early prostate cancer--which treatment do men prefer and why?

@en

Early prostate cancer--which treatment do men prefer and why?

@nl

prefLabel

Early prostate cancer--which treatment do men prefer and why?

@en

Early prostate cancer--which treatment do men prefer and why?

@nl

P1433

Q43916829-BC0C20F5-052F-4C5E-888A-9DB25570AD91

P1476

Q43916829-DCD8531E-5AB0-4825-81CF-61D003F15F83

P2093

Q43916829-0B2F2F06-14C1-42E7-A0DC-2D9690191F22

Q43916829-1897274B-0F88-4417-B39C-C34107275CD2

Q43916829-2C538C58-AC80-4BD7-81B4-B55DFD55017A

Q43916829-40380A35-842F-42BF-A5A4-DC3D9BDCEDB6

Q43916829-55907823-930E-4CE6-852F-63308BFFDC2F

Q43916829-657438AC-FEA2-4AED-B78C-2EF0A0BE1E5A

Q43916829-9E900B3E-450A-445C-96E7-85549F9E77D5

Q43916829-AA9CFD99-360A-439F-9BDE-61F0FE09882D

Q43916829-AC60D776-4206-4A4F-86C2-64161FEF2149

Q43916829-B1D8E10E-6D47-4C7B-9E39-70C16920DFCD

P2860

Q43916829-1DCE958B-4CD8-4242-A678-D0FCC9100BD6

Q43916829-36E6B3BC-5D57-4932-8A35-64A33E92D374

Q43916829-398A0B26-8167-45E8-8D2F-7287986C56ED

Q43916829-3E1A2D34-B41C-433B-A89E-844A53717CBC

Q43916829-412A6355-F697-4F5F-9BEE-A555B329100F

Q43916829-4382E769-A6F9-4736-92B0-A5DA8FD6320B

Q43916829-5981C3F2-B26D-4324-8B9E-EE10B47322EC

Q43916829-5F3186CD-D7D0-4819-BF8B-0D3F31548168

Q43916829-6033917C-F42B-4F93-92EB-882714E8E94A

Q43916829-6CDE81F5-8E23-408B-8A78-E99C73ED1F3F

P304

Q43916829-4FA9ED7F-8471-4DF7-BAA4-FA1C869C6B57

P31

Q43916829-9C0F09EB-75F3-40B3-8DF0-B0650D231E40

P356

Q43916829-9EEA5FAB-A9F2-404B-BB7C-971E1198174B

P433

Q43916829-BCD44425-A753-4855-95A0-E48876A05AD7

P478

Q43916829-2C1CDA13-DCCD-4E25-B79C-0898AF4793D2

P50

Q43916829-24D15F86-8CD4-45BB-B325-E3D49B87C25E

Q43916829-38EF15F3-06BF-4663-9780-D39AD3F3AFDE

Q43916829-8EAD1666-2E0B-4685-979A-2664E031A092

P577

Q43916829-3D527372-D3B9-47C8-8350-FB91EB31CD9B

P698

Q43916829-3BC6FB94-52D0-43EB-9BC2-F33232B218F3

P356

J.1464-410X.2010.09833.X

P1433

BJU International

P1476

Early prostate cancer--which treatment do men prefer and why?

@en

P2093

Carmel N Anandadas

http://www.w3.org/2001/XMLSchema#string

Gerald N Collins

http://www.w3.org/2001/XMLSchema#string

Guy D Wemyss-Holden

http://www.w3.org/2001/XMLSchema#string

James P Wylie

http://www.w3.org/2001/XMLSchema#string

John P Logue

http://www.w3.org/2001/XMLSchema#string

Lynne Gilmore

http://www.w3.org/2001/XMLSchema#string

Maurice W Lau

http://www.w3.org/2001/XMLSchema#string

North West Uro-oncology Group

http://www.w3.org/2001/XMLSchema#string

Patrick H O'Reilly

http://www.w3.org/2001/XMLSchema#string

Pradip M Javle

http://www.w3.org/2001/XMLSchema#string

P2860

Why patients choose prostatectomy or brachytherapy for localized prostate cancer: results of a descriptive survey.

The patient's dilemma: prostate cancer treatment choices.

Treatment decisions for localized prostate cancer: asking men what's important.

Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study.

Active surveillance: towards a new paradigm in the management of early prostate cancer.

Information needs of cancer patients in west Scotland: cross sectional survey of patients' views.

A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival.

What is the best approach for screen-detected low volume cancers?--The case for observation.

Patient-focussed decision-making in early-stage prostate cancer: insights from a cognitively based decision aid.

Counseling the patient with localized prostate cancer.

P304

1762-1768

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1464-410X.2010.09833.X

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P50

Susan E. Davidson

Richard A. Cowan

P577

2010-11-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21083643

http://www.w3.org/2001/XMLSchema#string